3 Smartest Dividend Stocks to Buy Now
When the market entered a correction in February and March,…
Buy
59
CNA Quote, Financials, Valuation and Earnings
Last price:
$50.63
Seasonality move
:
2.54%
Day range:
$50.24 - $51.03
52-week range:
$42.33 - $52.36
Dividend yield:
3.51%
P/E ratio:
14.43x
P/S ratio:
0.99x
P/B ratio:
1.31x
Volume:
318K
Avg. volume:
450.2K
1-year change:
11.82%
Market cap:
$13.8B
Revenue:
$14B
EPS (TTM):
$3.52
Analysts' Opinion
-
Consensus RatingCNA Financial has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $48.00, CNA Financial has an estimated downside of -5.49% from its current price of $50.79.
-
Price Target UpsideAccording to analysts, the highest upside price target is $53.00 representing -100% upside increase from its current price of $50.79.
Fair Value
-
According to the consensus of 1 analyst, CNA Financial has -5.49% downside to fair value with a price target of $48.00 per share.
CNA vs. S&P 500
-
Over the past 5 trading days, CNA Financial has overperformed the S&P 500 by 3.81% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
CNA Financial does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
CNA Financial has grown year-over-year revenues for 10 quarters straight. In the most recent quarter CNA Financial reported revenues of $3.6B.
Earnings Growth
-
CNA Financial earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter CNA Financial reported earnings per share of $0.07.
Enterprise value:
14.2B
EV / Invested capital:
--
Price / LTM sales:
0.99x
EV / EBIT:
10.54x
EV / Revenue:
1.01x
PEG ratio (5yr expected):
0.51x
EV / Free cash flow:
5.72x
Price / Operating cash flow:
5.59x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
1.46%
Net Income Margin (TTM):
6.85%
Return On Equity:
9.46%
Return On Invested Capital:
7.25%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $11.9B | $13.1B | $14B | $3.4B | $3.6B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $2.53 | $4.43 | $3.52 | $1.35 | $0.07 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $9.4B | $10.9B | $48.5B | $11.4B | $12.3B | |
| Total Assets | $64B | $66.6B | $61B | $64.7B | $66.5B | |
| Current Liabilities | -- | -- | -- | $550M | -- | |
| Total Liabilities | $51.3B | $53.8B | $52.5B | $54.8B | $56B | |
| Total Equity | $12.7B | $12.8B | $8.5B | $9.9B | $10.5B | |
| Total Debt | $2.8B | $2.8B | $2.8B | $3B | $3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.5B | $2.3B | $2.6B | $520M | $703M | |
| Cash From Investing | -$1.5B | -$1.8B | -$1.3B | -$306M | -$555M | |
| Cash From Financing | -$1B | -$577M | -$1.1B | -$359M | -$119M | |
| Free Cash Flow | $2.5B | $2.2B | $2.5B | $497M | $665M | |
CNA
Sector
Market Cap
$13.8B
$614.3M
Price % of 52-Week High
97%
85.46%
Dividend Yield
3.51%
1.98%
Shareholder Yield
8.38%
3.73%
1-Year Price Total Return
11.82%
7.6%
Beta (5-Year)
0.473
0.558
Dividend yield:
3.51%
Annualized payout:
$3.76
Payout ratio:
106.88%
Growth streak:
1 years
Technicals
8-day SMA
Buy
Level
$49.98
200-day SMA
Buy
Level
$48.52
Bollinger Bands (100)
Buy
Level
47.85 - 49.73
Chaikin Money Flow
Sell
Level
-1.4M
20-day SMA
Buy
Level
$49.16
Relative Strength Index (RSI14)
Buy
Level
61.40
ADX Line
Buy
Level
27.3
Williams %R
Sell
Level
-13.1894
50-day SMA
Buy
Level
$49.05
MACD (12, 26)
Buy
Level
13.98
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Sell
Level
-1.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.8433)
Sell
CA Score
(Annual)
Level (-1.8712)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (0.8097)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
CNA Financial Corporation (CNAF) is an insurance holding company that provides commercial property and casualty insurance. The company operates under five segments: Specialty, Commercial and International being its core business, and two segments for its non-core businesses, which are Life and Group and Corporate and Other. CNAF, through its segments, provides professional, financial, specialty property, and casualty products to small businesses and medium-scale organizations. It has its business spread across Continental Europe, United Kingdom, and Canada. The majority of the revenues are generated from the Specialty and Commercial segment of the business.
Stock Forecast FAQ
In the current month, CNA has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The CNA average analyst price target in the past 3 months is $48.00.
-
Where Will CNA Financial Stock Be In 1 Year?
According to analysts, the consensus estimate is that CNA Financial share price will drop to $48.00 per share over the next 12 months.
-
What Do Analysts Say About CNA Financial?
Analysts are divided on their view about CNA Financial share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CNA Financial is a Sell and believe this share price will rise from its current level to $43.00.
-
What Is CNA Financial's Price Target?
The price target for CNA Financial over the next 1-year time period is forecast to be $48.00 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is CNA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for CNA Financial is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of CNA?
You can purchase shares of CNA Financial via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CNA Financial shares.
-
What Is The CNA Financial Share Price Today?
CNA Financial was last trading at $50.63 per share. This represents the most recent stock quote for CNA Financial. Yesterday, CNA Financial closed at $50.79 per share.
-
How To Buy CNA Financial Stock Online?
In order to purchase CNA Financial stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is down 16.21% over the past day.
Sell
16
PCVX alert for Apr 1
Vaxcyte [PCVX] is down 2.91% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is down 3.23% over the past day.
